backaway, that is all we can do right now is speculate in regards to the microbanks.. I'm hoping they had some type of basis for their forecast.
As far as revenue, they have other subsidiaries besides the microbanks. They also stated in their 8/15 pr that they ANTICIPATE "revenues will increase throughout the balance of 2006, not only due to launching LifeStem's Stem Cell Microbank(TM) Collection Service, but also due to two subsidiaries, Molecula, Inc. and KD Medical, Inc., having combined operations to be more efficient and having moved into a new facility that should increase quality and improve manufacturing capabilities".
Like you said, their results will tell the story. All of the above is purely speculation, but I believe stem cell research, therapeutics and applications growing(in demand and $$) in the coming years is not even worth debating... it is still in its infancy stages. GLTY
